Ketamine Recruiting Phase 2 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03414931NMDA Modulation in Major Depressive Disorder in Late- Life